Citation: Yc. Tsang et al., HIGH VARIABILITY IN DRUG PHARMACOKINETICS COMPLICATES DETERMINATION OF BIOEQUIVALENCE - EXPERIENCE WITH VERAPAMIL, Pharmaceutical research, 13(6), 1996, pp. 846-850
Citation: M. Spino et al., THEOPHYLLINE RIBOSYLATION - STUDIES ON ENZYME CHARACTERIZATION AND IDENTITY, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 221-221
Authors:
JONES CL
VIETH R
SPINO M
LEDERMANN S
KOOH SW
BALFE J
BALFE JW
Citation: Cl. Jones et al., COMPARISONS BETWEEN ORAL AND INTRAPERITONEAL 1,25-DIHYDROXYVITAMIN D-3 THERAPY IN CHILDREN TREATED WITH PERITONEAL-DIALYSIS, Clinical nephrology, 42(1), 1994, pp. 44-49
Citation: M. Spino et al., VARIABILITY IN VERAPAMIL BIOAVAILABILITY FROM ISOPTIN SR COMPLICATES DETERMINATION OF BIOEQUIVALENCE, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 167-167
Citation: J. He et al., THEOPHYLLINE RIBOSYLATION OCCURS IN MICROSOMES PREPARED FROM ALL VITAL ORGANS, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 176-176
Citation: M. Levy et M. Spino, NEONATAL WITHDRAWAL SYNDROME - ASSOCIATED DRUGS AND PHARMACOLOGICAL MANAGEMENT, Pharmacotherapy, 13(3), 1993, pp. 202-211